Equities rallied Monday after data showed high efficacy for an AstraZeneca (AZN) vaccine that could be more easily distributed than its peers.


by Pinnacle Report Leave a Comment
Investing| Kiplinger- Investing| 5 years ago
Equities rallied Monday after data showed high efficacy for an AstraZeneca (AZN) vaccine that could be more easily distributed than its peers.
"I think you have to buy a couple of these vaccine winners on any weakness, although when it comes to retail, I just say buy some," the "Mad Money" host…
Spend time every day learning something new.
Allianz Global Investors’ Mona Mahajan paints a bullish long-term picture that's tied to a key advancement on the coronavirus front and politics.
Be the first to get the latest updates and more!
Leave a Reply